Free Trial

CME Group Inc. (NASDAQ:CME) Stock Holdings Increased by Resona Asset Management Co. Ltd.

CME Group logo with Finance background

Key Points

  • Resona Asset Management Co. Ltd. increased its stake in CME Group Inc. by 7.5%, owning a total of 123,828 shares worth approximately $32.8 million at the end of the first quarter.
  • CME Group reported a quarterly earnings per share of $2.96, exceeding the consensus estimate by $0.05, alongside a 10.4% increase in revenue compared to the same quarter last year.
  • The company announced a quarterly dividend of $1.25 per share, representing an annualized dividend of $5.00 and a yield of 1.7% for stockholders of record.
  • Want stock alerts on CME Group? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Resona Asset Management Co. Ltd. lifted its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 7.5% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 123,828 shares of the financial services provider's stock after purchasing an additional 8,685 shares during the period. Resona Asset Management Co. Ltd.'s holdings in CME Group were worth $32,798,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in CME. Wayfinding Financial LLC acquired a new position in shares of CME Group during the first quarter valued at about $25,000. Cornerstone Planning Group LLC increased its holdings in shares of CME Group by 122.2% during the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock valued at $26,000 after acquiring an additional 55 shares in the last quarter. Golden State Wealth Management LLC increased its holdings in shares of CME Group by 612.5% during the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock valued at $30,000 after acquiring an additional 98 shares in the last quarter. Alpine Bank Wealth Management acquired a new position in shares of CME Group during the first quarter valued at about $32,000. Finally, Financial Gravity Asset Management Inc. acquired a new position in CME Group in the 1st quarter worth approximately $32,000. 87.75% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

CME has been the topic of several research reports. JPMorgan Chase & Co. cut their price target on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating on the stock in a report on Thursday, April 24th. UBS Group reiterated a "neutral" rating and issued a $305.00 price target on shares of CME Group in a report on Thursday, July 24th. Barclays set a $298.00 price target on shares of CME Group and gave the stock an "equal weight" rating in a report on Thursday, July 24th. Oppenheimer increased their price target on shares of CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a report on Thursday, July 24th. Finally, Piper Sandler raised their price objective on shares of CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 15th. Four investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $261.93.

Read Our Latest Analysis on CME Group

CME Group Price Performance

CME Group stock traded down $0.78 during trading hours on Friday, hitting $273.92. The stock had a trading volume of 2,055,786 shares, compared to its average volume of 2,086,143. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The stock has a market capitalization of $98.72 billion, a price-to-earnings ratio of 26.52, a PEG ratio of 4.87 and a beta of 0.44. CME Group Inc. has a 1-year low of $204.16 and a 1-year high of $290.79. The stock's fifty day moving average is $275.52 and its two-hundred day moving average is $267.13.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, beating analysts' consensus estimates of $2.91 by $0.05. The business had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%. The business's revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter last year, the company earned $2.56 earnings per share. As a group, analysts predict that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th will be paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date of this dividend is Tuesday, September 9th. CME Group's dividend payout ratio (DPR) is presently 48.40%.

Insider Transactions at CME Group

In other news, General Counsel Jonathan L. Marcus sold 390 shares of the firm's stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $277.50, for a total value of $108,225.00. Following the transaction, the general counsel directly owned 6,708 shares in the company, valued at $1,861,470. This trade represents a 5.49% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Phyllis M. Lockett sold 1,060 shares of the firm's stock in a transaction dated Monday, May 19th. The stock was sold at an average price of $277.88, for a total value of $294,552.80. Following the completion of the transaction, the director owned 3,108 shares in the company, valued at approximately $863,651.04. This trade represents a 25.43% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 2,450 shares of company stock worth $676,663 in the last quarter. 0.30% of the stock is currently owned by corporate insiders.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Further Reading

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Soaring Valuation—Justified or Overhyped?
3 Stocks With Explosive Upside
September Slowdown: 3 Stocks to Buy When the Pullback Comes

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines